Reference
Tomita Y, et al. The safety and efficacy of cisplatin plus gemcitabine in recurrent ovarian cancer. International Journal of Clinical Oncology 19: 662-666, No. 4, Aug 2014. Available from: URL: http://doi.org/10.1007/s10147-013-0599-5 - Japan
Rights and permissions
About this article
Cite this article
Cisplatin/gemcitabine. Reactions Weekly 1526, 51 (2014). https://doi.org/10.1007/s40278-014-4698-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-4698-5